Navigating Aging

Doctors Weigh Pros and Cons of Prescribing Hot-Button Alzheimer’s Drug

The potential benefits of Aduhelm are small, its effectiveness is not certain, and even the FDA Thursday shifted its guidance on who should get the drug. But physicians are dealing with an onslaught of interest from patients and their families, and figuring out which patients are best positioned to be helped by the drug will be difficult.

Facebook Live: Helping COVID’s Secondary Victims: Grieving Families and Friends

More than 246,000 people in the U.S. have been killed by the coronavirus, leaving hundreds of thousands of others grieving. Judith Graham, author of KHN’s Navigating Aging column, hosted a discussion on these unprecedented losses and dealing with bereavement. She was joined by Holly Prigerson, co-director of the Center for Research on End-of-Life Care at Weill Cornell Medicine in New York City, and Diane Snyder-Cowan, leader of the bereavement professionals steering committee of the National Council of Hospice and Palliative Professionals.